baber/WOPTO huggingface dataset:
Patent AU-652467-B2 (AU)
Title: Direct molecular cloning of a modified eukaryotic cytoplasmic DNA virus genome
Inventor: DORNER FRIEDRICH
IPC: C12N5/00
Filed: 1992-08-25
Granted: 1994-08-25
Abstract: A method is disclosed for producing a modified eukaryotic cytoplasmic DNA virus by direct molecular cloning of a modified DNA molecule comprising a modified cytoplasmic DNA virus genome. The inventive method comprises the steps of (I) modifying under extracellular conditions a DNA molecule comprising a first cytoplasmic DNA virus genome to produce a modified DNA molecule comprising the modified cytoplasmic DNA virus genome; (II) introducing the modified DNA molecule into a first host cell which packages the modified DNA molecule into infectious virions; and (III) recovering from the host cell virions comprised of the modified viral genome. The host cell is infected with a helper virus which is expressed to package the modified viral genome into infectious virions. Examples of packaging a modified poxvirus genome by a helper poxvirus of the same or different genus are described. Also disclosed are novel poxvirus vectors for direct molecular cloning of open reading frames into a restriction enzyme cleavage site that is unique in the vector. In one model poxvirus vector, the open reading frame is transcribed by a promoter located in the vector DNA upstream of a multiple cloning site comprised of several unique cleavage sites.
Patent AU-763779-B2 (AU)
Title: Pharmaceutical formulation for intravenous or intramuscular octreotide administration
Inventor: OBIOLS BERTA PONSATI
IPC: A61K9/08
Filed: 2000-12-15
Granted: 2003-07-31
Abstract: A stable pharmaceutical formulation for intravenous or intramuscular administration of Octreotide, which is characterised in that the vehicle for injection of the peptide or pharmaceutically acceptable salts thereof contains glycine in concentrations ranging from 10 to 60 mM and aqueous solution of hydrochloric acid in sufficient quantity to adjust the pH of the formulation to values between 3.0 and 4.2. <IMAGE>
Patent AU-689573-B2 (AU)
Title: Crystalline hydrated layered sodium and potassium silicates and method of producing same
Inventor: BORGSTEDT ERIC VON REHREN
IPC: C01B33/38
Filed: 1995-03-15
Granted: 1998-04-02
Abstract: A crystalline hydrated layered sodium and potassium silicate/amorphous sodium and potassium silicate composite material with predetermined hardness ion sequestration properties is achieved by controlling the process for forming the material. The process for producing the crystalline hydrated layered sodium and potassium silicate/amorphous is sodium and potassium silicate composite comprises hydrolyzing DB-1 crystalline sodium and potassium silicate glasses as a precursor material to produce the composite material known as DB-2. Hydrolysis of the DB-1 precursor material is achieved by adding typically up to 100.0 milliequivalents per gram of H3O+ ions or up to 50 milliequivalents per gram of OH- ions. The resulting DB-2 material can sequester CA2+ ions, Mg+ ions, or both, depending on the results desired, processing conditions, and starting materials used.
Patent AU-742031-B2 (AU)
Title: Catheter system for administration of continuous peripheral nerve anesthetic
Inventor: GREENGRASS ROY A
IPC: A61B17/34
Filed: 1999-01-14
Granted: 2001-12-13
Abstract: A catheter system having an epidural needle, an electrically conductive stimulation wire attached to the needle, a multi-purpose connector, which is adapted to connect to intravenous tubing for supplying local anesthesia, and an epidural catheter for supplying regional anesthesia. When the connector and needle are connected to each other, an operator can insert the needle into a patient with the needle's distal end within the nerve sheath and proximate to the nerve plexus. A voltage is applied via the wire to determine correct positioning. Then, the operator can slide the catheter through the connector and needle until the catheter's distal end is protruding out of the needle's distal end and into the nerve sheath, proximate to the nerve plexus. Then, the needle (and its associated wire) and the connector (and its associated tubing) are slidably removed from the catheter, and the catheter may be left in place.
Patent AU-703963-B2 (AU)
Title: Heparin-binding protein for the treatment of sepsis and processes for its preparation
Inventor: FLODGAARD HANS JAKOB HEM
IPC: C12N15/12
Filed: 1995-03-17
Granted: 1999-04-01
Abstract: Pharmaceutical composition for the prevention or treatment of diseases or conditions associated with induction of the cytokine cascade by lipopolysaccharide (LPS), the composition comprising a heparin-binding protein (HBP) which, in glycosylated form, has an apparent molecular weight of 28 kD (as determined by SDS-PAGE under reducing conditions), the protein being produced in the azurophil granules of polymorphonuclear leukocytes, together with a pharmaceutically acceptable carrier or diluent. The heparin-binding protein is produced in host cells containing a DNA sequence encoding N-terminally extended HBP or encoding HBP preceded by and fused to a DNA sequence encoding another protein. Also disclosed is a process wherein the culture medium contains a sulphated polysaccharide.
Patent AU-565290-B2 (AU)
Title: Silanised-adsorbent containing deodorant
Inventor: FAIRHURST EDGAR
IPC: A61K8/34
Filed: 1984-01-31
Granted: 1987-09-10
Abstract: Silanised adsorbents may be used to reduce or prevent body odour.
Patent AU-757284-B2 (AU)
Title: Anti-viral vectors
Inventor: KINGSMAN ALAN JOHN
IPC: C12N7/00
Filed: 1999-02-17
Granted: 2003-02-13
Abstract: A viral vector production system is provided which system comprises: 
(i) a viral genome comprising at least one first nucleotide sequence encoding a gene product capable of binding to and effecting the cleavage, directly or indirectly, of a second nucleotide sequence, or transcription product thereof, encoding a viral polypeptide required for the assembly of viral particles; 
(ii) a third nucleotide sequence encoding said viral polypeptide required for the assembly of the viral genome into viral particles, which third nucleotide sequence has a different nucleotide sequence to the second nucleotide sequence such that said third nucleotide sequence, or transcription product thereof, is resistant to cleavage directed by said gene product.  The viral vector production system may be used to produce viral particles for use in treating or preventing viral infection.
Patent AU-571506-B2 (AU)
Title: Cristalline ceftazidime
Inventor: DURCKHEIMER WALTER
IPC: C07D501/46
Filed: 1984-04-16
Granted: 1988-04-21
Abstract: Anhydrous crystalline (6R,7R)-7-[(Z)-2-(2-aminothiazol-4-yl)-2-(2-carboxyprop-2-oximino)acet amido]-3-(1-pyridiniummethyl)-3-cephem-4-carboxylate and a process for its preparation, a pharmaceutical formulation which is active against bacterial infections and contains this compound and a process for the preparation of the formulation and the use of this compound for controlling bacterial infections.
Patent AU-771792-B2 (AU)
Title: Electrode for muscle stimulation
Inventor: BAR-OR JONATHAN
IPC: A61N1/04
Filed: 2001-03-19
Granted: 2004-04-01
Abstract: The invention provides an electrode kit for muscle stimulation to be used in conjunction with a splint, the kit including an electrode carrier (4) attachable to an interior surface of the splint and consisting of a relatively thin, flexible, tray-like member (4); a thin, flexible electrode member (6) fixedly attached to the electrode carrier (4), and a skin-contacting pad member (20) consisting of a piece of medium-absorptive material (22) fixedly mounted on a rigidifying frame (24) attachable to, and removable from, the electrode carrier (4). <IMAGE>
Patent AU-664867-B2 (AU)
Title: Weave shed formation apparatus
Inventor: KUSTER HEINZ
IPC: D03C13/00
Filed: 1992-10-13
Granted: 1995-12-07
Abstract: A shed formation apparatus having increased flexibility and speed. The shed formation apparatus is comprised of a plurality of movable heddles which are connected to a plurality of heddle selectors by a first plurality of control leads. The heddle selectors are movably connected to a plurality of heddle selector controllers which include stoppers to retard the movement of the heddle selectors. A second plurality of control leads are attached to the heddle selectors. A repeat pattern output apparatus determines the movement of the second plurality of control leads and the attached heddle selectors, and selectively activates the stoppers.
Patent AU-665788-B2 (AU)
Title: Bearing alarm
Inventor: RICHMOND ALLAN
IPC: F16C19/52
Filed: 1992-11-11
Granted: 1996-01-18
Abstract: The present invention relates to an alarm system suitable for use in warning of overheating in rotatable bearings (4) having first and second bearing portions. The alarm system comprises an alarm signal generator means having a thermally activated engagement element (8) on a first bearing portion or body (6) connected thereto. The element (8) is in thermal connection with the bearing (4) and is formed and arranged so as to be driven generally axially of the rotatable bearing from a first primed retracted position into a second deployed extended alarm position upon reaching a predetermined temperature. In the alarm position the element (8) contacts an engaging portion (12) on the second bearing portion so as to produce a distinctive alarm signal indicating that said bearing (4) has exceeded the predetermined temperature.
Patent AU-724467-B2 (AU)
Title: TIE-2 receptor ligand (TIE ligand-4) and its uses
Inventor: VALENZUELA DAVID M
IPC: C12N15/85
Filed: 1997-06-19
Granted: 2000-09-21
Abstract: The present invention provides for an isolated nucleic acid molecule encoding a member of the TIE ligand family. The present invention also provides for an isolated nucleic acid molecule encoding TIE ligand-3 or TIE ligand-4. In addition, the invention provides for a receptorbody which specifically binds TIE ligand-3 or TIE ligand-4. The invention also provides an antibody which specifically binds TIE ligand-3 or TIE ligand-4. The invention further provides for an antagonist of TIE. The invention also provides for therapeutic compositions as well as a method of blocking blood vessel growth, a method of promoting neovascularization, a method of promoting the growth or differentiation of a cell expressing the TIE receptor, a method of blocking the growth or differentiation of a cell expressing the TIE receptor and a method of attenuating or preventing tumor growth in a human.
Patent AU-679649-B2 (AU)
Title: Antiviral activity of 2-hydroxymethyl-5-(5-fluorocytosin-1- YL)-1,3-oxathiolane
Inventor: LIOTTA DENNIS C
IPC: A61P37/04
Filed: 1995-11-20
Granted: 1997-07-03
Abstract: Enantiomerically enriched cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolane-5-yl)-(1H)-pyrimidin-2-one, derivatives and pharmaceutical compositions thereof.
Patent AU-623422-B2 (AU)
Title: Diorganopolysiloxane derivatives, their preparation and their use
Inventor: CANIVENC EDITH
IPC: C08G77/38
Filed: 1989-08-02
Granted: 1992-05-14
Abstract: The present invention relates to a diorganopolysiloxane containing a dibenzoylmethane functional group, chosen from those of formula: 
<IMAGE>
 and 
<IMAGE>
 in which: - A and/or B is a dibenzoylmethane group. 
<??>The invention also relates to a process for preparing polymers of formulae (1) and (2), and to their use, in particular as a lubricant for PVC.
Patent AU-700005-B2 (AU)
Title: Technical and non-technical textile products and packaging materials
Inventor: LORCKS JURGEN
IPC: C08J5/18
Filed: 1995-12-20
Granted: 1998-12-17
Abstract: Articles of manufacture which comprise biodegradable fibers and fabrics made therefrom. The fibers are made from starch-based biodegradable thermoplastic polymers, which preferably include a an additional biodegradable thermoplastic polymer blended with thermoplastic starch for improved chemical and physical properties. Threads or fibers for the manufacture of these articles are drawn in a process that improves their mechanical properties, particularly their strength. These threads or fibers can be used in the manufacture of articles that have open, semi-densely packed or densely packed structures.
Patent AU-714739-B2 (AU)
Title: Pressurized fluid container
Inventor: SCHMIDT FRANKLIN T
IPC: F23D14/28
Filed: 1997-08-12
Granted: 2000-01-13
Abstract: An LPG canister connector for a combustion appliance having a flow path from a canister containing liquid fuel and having a cap with outlet means at the upstream end of the flow path, a valve assembly adapted to be connected to the cap and equipped with a conduit adapted to be connected to a combustion appliance at the downstream end of the flow path, and promoters for vaporization of said fuel being located intermediate the ends of the flow path.
Patent AU-765806-B2 (AU)
Title: Height adjustment device, particularly for the seat back portion and arm-rests in office chairs
Inventor: GORGI CLAUDIO
IPC: A47C1/03
Filed: 2000-03-02
Granted: 2003-10-02
Abstract: A height adjustment device, in particular for seat back portions and arm-rests in office chairs, comprising a guide element (14, 48) rigid with the support plate (10) for the seating portion (12), a slide (22, 42) supporting the movable part (18, 20) and engagable with and slidable along said guide element, and means (38) selectively engagable in one of a plurality of teeth (31) to provide a configuration of stability, said selectively engagable means sliding freely along the passive flanks of the teeth of the toothed portion during the raising of the movable part, and lockable by the active flanks each time a tooth is passed over, said selectively engagable means being disengagable, for a predetermined position of said slide (22, 42) relative to said guide element (14, 48), from said teeth thus enabling said slide to move by gravity along said guide element, characterized in that said toothed portion (28) is faced by a toothed counter-portion (32) the teeth (34) of which form with the teeth (31) of said toothed portion (28) a mixed-line channel, the roots (30, 33) of the teeth (31, 34) of said toothed portion (28) and counter-toothed portion (32) forming respectively the seat of stable configuration and of temporary obstacle to the movement of said selectively engagable means along the mixed-line channel.
Patent AU-663792-B2 (AU)
Title: Method and apparatus for measuring meteorological visibility and scattering of light said apparatus utilizing common optics for transmission and reception
Inventor: LONNQVIST JAN
IPC: G01S7/481
Filed: 1993-07-21
Granted: 1995-10-19
Abstract: The invention concerns a method and an apparatus for measuring the meteorological visibility and the scattering of light. According to the method, a light pulse is emitted into the atmosphere via an optical transmit system (7, 9), the backscattered light returns via the optical transmit system (7, 9) after which its intensity and delay are measured. According to the invention, the waveform of the optical transmit pulse generated at the instant of its launching from within the apparatus is sensed in a manner that excludes any backscattered light originating from outside the measurement system, this signal is scaled for both its magnitude and phase so as to achieve a suitable feedback signal relative to the actual measurement signal and said feedback signal is subtracted from said measurement signal to avoid overloading of the receiver. <IMAGE>
Patent AU-634178-B2 (AU)
Title: Oral immunization by transgenic plants
IPC: A61K39/00
Filed: 1989-09-05
Granted: 1993-02-18
Abstract: The invention is directed to transgenic plants expressing colonization and/or virulence antigens specified by genes from pathogenic microorganisms. It is also directed to the use of such transgenic plants for oral immunization of humans and other animals to elicit a secretory immune response which inhibits colonization of or invasion by such pathogenic microorganisms through a mucosal surface of humans or other animals.
Patent AU-568436-B2 (AU)
Title: Office desk for peripheral computer equipment
Inventor: VEYHL WOLF
IPC: A47B17/00
Filed: 1985-05-31
Granted: 1987-12-24
Abstract: An office desk suited in particular for peripheral computer equipment consists of two side parts formed by columns provided with feet, a longitudinal beam detachably connected with the columns by connection elements establishing a form-locking connection, and of carrying arms for at least one table top mounted on the longitudinal beam. These components can be varied in many different ways and combined in the most different manners so that office desks optimally adapted in each case to the respective application can be realized with the same basic elements.
Patent AU-671650-B2 (AU)
Title: Extraction method for sealed flexible bags and device therefor
Inventor: FOND OLIVIER
IPC: A47J/
Filed: 1993-07-12
Granted: 1996-09-05
Abstract: The sachet (1) is made from two identical supple sheets which are joined round their periphery. It is held in a closed chamber. This has a lower part (2), that holds the sachet, to which an upper piece (8) is clipped. The method includes introducing a mixture of air and water, under pressure, into the chamber, through a hole (10) in the upper part. Spikes (11) on the base of the upper part pierce the upper surface of the sachet. Its lower surface is pressed on to points (19) on the lower part. These have holes (20) between them through which the liquid flows.
Patent AU-771858-B2 (AU)
Title: Assays for nucleoside diphosphates and triphospates
Inventor: BRUNE MARTIN HERMANN KLEMENS
IPC: C12R1/01
Filed: 2000-05-05
Granted: 2004-04-01
Abstract: Nucleoside diphosphates (NDPs) are detected or measured by following the dephosphorylation of the phosphoenzyme form of nucleoside diphosphate kinase (NDPK), and nucleoside triphosphates (NTPs) are detected or measured by following the phosphorylation of NDPK to its phosphoenozyme form. A typical process involves (a) causing NDP in sample to bind to NDPK phosphoenzyme, or causing NTP in sample to phosphorylate NDPK and (b) detecting a change in a characteristic of the enzyme which differs between its phosphorylated and unphosphorylated forms. This may be aided by labelling the enzyme. Quantitative data can be obtained. Both in vivo and in vitro measurements can be made.
Patent AU-759046-B2 (AU)
Title: Information-bearing discs and methods of fabrication
Inventor: KERN ELLIS E
IPC: G11B7/26
Filed: 1999-09-02
Granted: 2003-04-03
Abstract: Information-bearing discs (10) are fabricated from a first disc (20) and a second (30) disc. The first disc has a first substantially planar surface (22a) and a second surface (22b) opposite to the first surface. The second surface has first information recorded on it by means of local changes in the distance of the second surface from the first surface. The second disc is thicker than the first disc and has opposite, substantially planar, third and fourth surfaces (32a,32b). The fourth surface may have second information recorded on it by means of local changes in the distance of the fourth surface from the third surface. The second disc is secured to the first disc so that the fourth surface faces the second surface. The added thickness of the second disc eliminates rippling and buckling problems associated with bonding the discs. <IMAGE>
Patent AU-666767-B2 (AU)
Title: NANBV diagnostics and vaccines
Inventor: HOUGHTON MICHAEL
IPC: A61K39/12
Filed: 1993-09-21
Granted: 1996-02-22
Abstract: A pharmaceutical composition comprising a hepatitis C virus (HCV) antisense polynucleotide which is selectively hybridizable for the sense strand of the genome of an HCV, wherein the polynucleotide comprises a contiguous sequence of at least 8 nucleotides complementary to the sense strand of the genome of an HCV and a pharmaceutically acceptable excipient, wherein HCV is characterized by:  (i) a positive stranded RNA genome; (ii) said genome comprising an open reading frame (ORF) encoding a polyprotein; and (iii) said polyprotein is encoded by an HCV genome wherein the HCV genome has an homology at the polypeptide level of at least 40% to the 169 amino acid sequence shown in Figure 11.
Patent AU-630398-B2 (AU)
Title: Drop cable
Inventor: WETTENGEL PAUL FREDERICK
IPC: H02G7/02
Filed: 1989-12-01
Granted: 1992-10-29
Abstract: A drop cable arrangement in which a carried line (9) is supported by a strength member (3), the carried line being attached to the strength member via a tubular member (7) that is a sufficiently loose fit around the strength member to permit relative longitudinal movement therebetween. In the event of additional loading on the drop cable the strength member extends due to the increased tension, but this tension is not transferred to the carried line due to the permitted relative movement of the tubular member and strength member.
Patent AU-730372-B2 (AU)
Title: Use of an extract of Cimicifuga
Inventor: NESSELHUT THOMAS
IPC: A61P35/00
Filed: 1997-12-11
Granted: 2001-03-08
Abstract: Composition, including pharmaceutical compositions, containing a combination of antiestrogenic compounds. Methods of treatment using extracts of the plant Cimicifuga, alone or in combination with at least one antiestrogenic compound, which avoid or diminish unwanted side-effects and provide increased therapeutic benefit.
Patent AU-654466-B2 (AU)
Title: Tampon with single layer powder bonded wrap
Inventor: ALIKHAN MIR I
IPC: A61F13/15
Filed: 1989-12-14
Granted: 1994-11-10
Abstract: A tampon having a single layer wrap of fibers attached together by a powder binder. The wrap is embossed around a tampon pledget. The wrap in one embodiment includes a blend of hydrophobic synthetic fibers and hydrophilic cellulosic fibers laminated together with bonding powder. Another embodiment has only hydrophilic cellulosic fibers laminated together with bonding powder.
Patent AU-670842-B2 (AU)
Title: Tropone-substituted phenyloxazolidinone antibacterial agents
Inventor: BARBACHYN MICHAEL ROBERT
IPC: A61K31/54
Filed: 1993-10-14
Granted: 1996-08-01
Abstract: A novel class of phenyloxazolidinone antibacterial agents which have, as their salient structural feature, an appended substituted tropone moiety, are described. Intermediates and processes for the preparation of these antibiotics are also disclosed. These compounds are useful antibacterial agents to eradicate or control susceptible organisms.    <IMAGE>  I  wherein R4 is oxygen substituted heptatrienyl and R1, R2, and R3 are as defined herein.
Patent AU-638989-B2 (AU)
Title: Container
IPC: B01L3/14
Filed: 1990-04-12
Granted: 1993-07-15
Abstract: A container or vessel useful in the preparation of bacterial extracts or similar analytical samples, constructed of resilient flexible plastics material and having a releasably engageable cap (3) incorporating a nozzle (8) through which liquid contents of the container may be expressed by squeezing the container, the cap being linked to the container by a double hinge comprising two strips (14a, 14b) of material which fold back upon themselves when the container is closed by the cap, the apices (18a, 18b) of the folded hinge strips together providing contact points upon which the capped end of the container may be rested on a horizontal surface such as a work bench.
Patent AU-678793-B2 (AU)
Title: Pressure sensitive adhesives comprising liquid and solid rubbers
Inventor: KORPMAN RALF
IPC: C09J121/02
Filed: 1993-11-16
Granted: 1997-06-12
Abstract: This invention relates to a novel pressure sensitive adhesive formed of a liquid and solid rubber which is substantially resin free. Preferably the adhesive is formed of a weight ratio of solid rubber to liquid rubber of about 1:0.5 to about 1:7. These adhesives exhibit improved adhesion in cold weather and oily surface applications and other properties. The pressure sensitive adhesives can be used in health care, industrial and drug delivery systems.